IRIS Accounts Production v25.4.0.155 01029790 director 1.3.24 28.2.25 28.2.25 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh010297902024-02-29010297902025-02-28010297902024-03-012025-02-28010297902023-02-28010297902023-03-012024-02-29010297902024-02-2901029790ns15:EnglandWales2024-03-012025-02-2801029790ns14:PoundSterling2024-03-012025-02-2801029790ns10:Director12024-03-012025-02-2801029790ns10:PrivateLimitedCompanyLtd2024-03-012025-02-2801029790ns10:SmallEntities2024-03-012025-02-2801029790ns10:AuditExempt-NoAccountantsReport2024-03-012025-02-2801029790ns10:SmallCompaniesRegimeForDirectorsReport2024-03-012025-02-2801029790ns10:SmallCompaniesRegimeForAccounts2024-03-012025-02-2801029790ns10:FullAccounts2024-03-012025-02-2801029790ns10:OrdinaryShareClass12024-03-012025-02-2801029790ns10:RegisteredOffice2024-03-012025-02-2801029790ns5:CurrentFinancialInstruments2025-02-2801029790ns5:CurrentFinancialInstruments2024-02-2901029790ns5:ShareCapital2025-02-2801029790ns5:ShareCapital2024-02-2901029790ns5:RetainedEarningsAccumulatedLosses2025-02-2801029790ns5:RetainedEarningsAccumulatedLosses2024-02-2901029790ns5:LandBuildingsns5:ShortLeaseholdAssets2024-03-012025-02-2801029790ns5:PlantMachinery2024-03-012025-02-2801029790ns5:FurnitureFittings2024-03-012025-02-2801029790ns5:ComputerEquipment2024-03-012025-02-2801029790ns5:LandBuildingsns5:ShortLeaseholdAssets2024-02-2901029790ns5:PlantMachinery2024-02-2901029790ns5:FurnitureFittings2024-02-2901029790ns5:ComputerEquipment2024-02-2901029790ns5:LandBuildingsns5:ShortLeaseholdAssets2025-02-2801029790ns5:PlantMachinery2025-02-2801029790ns5:FurnitureFittings2025-02-2801029790ns5:ComputerEquipment2025-02-2801029790ns5:LandBuildingsns5:ShortLeaseholdAssets2024-02-2901029790ns5:PlantMachinery2024-02-2901029790ns5:FurnitureFittings2024-02-2901029790ns5:ComputerEquipment2024-02-2901029790ns5:WithinOneYearns5:CurrentFinancialInstruments2025-02-2801029790ns5:WithinOneYearns5:CurrentFinancialInstruments2024-02-2901029790ns5:WithinOneYear2025-02-2801029790ns5:WithinOneYear2024-02-2901029790ns5:BetweenOneFiveYears2025-02-2801029790ns5:BetweenOneFiveYears2024-02-2901029790ns5:MoreThanFiveYears2025-02-2801029790ns5:MoreThanFiveYears2024-02-2901029790ns5:AllPeriods2025-02-2801029790ns5:AllPeriods2024-02-2901029790ns10:OrdinaryShareClass12025-02-2801029790ns5:RetainedEarningsAccumulatedLosses2024-02-2901029790ns5:RetainedEarningsAccumulatedLosses2024-03-012025-02-28
REGISTERED NUMBER: 01029790 (England and Wales)







Unaudited Financial Statements

for the Year Ended 28th February 2025

for

Barton Pharmacy Limited

Barton Pharmacy Limited (Registered number: 01029790)






Contents of the Financial Statements
for the Year Ended 28th February 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Barton Pharmacy Limited

Company Information
for the Year Ended 28th February 2025







DIRECTOR: Mr H Chaggar





REGISTERED OFFICE: Ground Floor
3 West Road
Woolacombe
Devon
EX34 7BW





REGISTERED NUMBER: 01029790 (England and Wales)





ACCOUNTANTS: Dunkley's
Woodlands Grange
Woodlands Lane
Bradley Stoke
Bristol
United Kingdom
BS32 4JY

Barton Pharmacy Limited (Registered number: 01029790)

Balance Sheet
28th February 2025

28.2.25 29.2.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 6,925 5,582

CURRENT ASSETS
Stocks 10,194 14,137
Debtors 5 263,946 179,701
Cash at bank and in hand 29,571 16,107
303,711 209,945
CREDITORS
Amounts falling due within one year 6 73,284 73,983
NET CURRENT ASSETS 230,427 135,962
TOTAL ASSETS LESS CURRENT LIABILITIES 237,352 141,544

PROVISIONS FOR LIABILITIES 1,047 1,259
NET ASSETS 236,305 140,285

CAPITAL AND RESERVES
Called up share capital 8 100 100
Retained earnings 9 236,205 140,185
SHAREHOLDERS' FUNDS 236,305 140,285

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28th February 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 28th February 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 27th November 2025 and were signed by:





Mr H Chaggar - Director


Barton Pharmacy Limited (Registered number: 01029790)

Notes to the Financial Statements
for the Year Ended 28th February 2025

1. STATUTORY INFORMATION

Barton Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Short leasehold - 10% on cost
Plant and machinery - 20% on reducing balance
Fixtures and fittings - 20% on reducing balance
Computer equipment - 33.33% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Leasing agreements
Rentals paid under operating leases are charged to the profit or loss on a straight line basis over the period of the lease. Some lease agreements hold an option to buy at the end of the lease. This option to buy is not determined until the lease is over and is assessed on an item by item basis. If the option to buy is exercised, the item will be capitalised and depreciated accordingly.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 5 (2024 - 5 ) .

Barton Pharmacy Limited (Registered number: 01029790)

Notes to the Financial Statements - continued
for the Year Ended 28th February 2025

4. TANGIBLE FIXED ASSETS
Fixtures
Short Plant and and Computer
leasehold machinery fittings equipment Totals
£    £    £    £    £   
COST
At 1st March 2024 30,627 1,908 40,428 1,904 74,867
Additions 2,693 125 270 - 3,088
At 28th February 2025 33,320 2,033 40,698 1,904 77,955
DEPRECIATION
At 1st March 2024 30,224 633 38,322 106 69,285
Charge for year 434 255 421 635 1,745
At 28th February 2025 30,658 888 38,743 741 71,030
NET BOOK VALUE
At 28th February 2025 2,662 1,145 1,955 1,163 6,925
At 29th February 2024 403 1,275 2,106 1,798 5,582

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
28.2.25 29.2.24
£    £   
Trade debtors 79 6,827
Owed by parent company 203,252 123,152
Other debtors 3,198 -
Tax - 3,281
VAT 5,624 7,327
Accrued income 51,638 38,967
Prepayments 155 147
263,946 179,701

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
28.2.25 29.2.24
£    £   
Trade creditors 29,105 28,797
Tax 28,608 29,257
Social security and other taxes 414 76
Directors' current accounts 15,157 14,845
Accrued expenses - 1,008
73,284 73,983

7. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
28.2.25 29.2.24
£    £   
Within one year 29,000 29,000
Between one and five years 145,000 145,000
In more than five years 29,000 87,000
203,000 261,000

Barton Pharmacy Limited (Registered number: 01029790)

Notes to the Financial Statements - continued
for the Year Ended 28th February 2025

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 28.2.25 29.2.24
value: £    £   
100 Ordinary £1 100 100

9. RESERVES
Retained
earnings
£   

At 1st March 2024 140,185
Profit for the year 101,020
Dividends (5,000 )
At 28th February 2025 236,205